Maze Therapeutics, Inc.
← Back to MAZE Overview

Maze Therapeutics, Inc. (MAZE)

Price-to-Earnings Ratio History

P/E Ratio (TTM)

-16.58

Financial Fundamentals

MAZEQuarterly Data • 5Y View

Quarterly P/E

QuarterP/E Ratio
2023-09-30-7.05
2023-12-31-6.57
2024-03-31-5.37
2024-06-304.07
2024-09-30-71.98
2024-12-31-35.60
2025-03-31-3.68
2025-06-30-3.98
2025-09-30-9.82
2025-12-31-11.91
2026-03-31-16.58

* P/E ratios are calculated using trailing twelve-month (TTM) earnings.